Conference abstractPublished 10 Jun 2013
A small scale Phase IV clinical study dealing with cardiotoxicity after cancer treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
New drug discovery in the pediatrics has dramatically improved survival, but with long- term adverse events. This motivates the examination of adverse outcomes such as long-term toxicity in a Phase IV trial. An ideal approach to monitor long-term toxicity is to systematically follow the survivors, which is generally not feasible. Instead, cross-sectional surveys are conducted, such as Hudson et al. (2007), with one of the objectives to estimate the cumulative incidence rates along with specific interest in fixed-term (5 or 10 year) rates. We present inference procedures based on current status data to our motivating example with very interesting findings.
Subjects
Mathematics & StatisticsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biometrics & Biostatistics
- SubjectMathematics & Statistics
- BylineArticles whose byline prints “Shesh N Rai”
- BylineArticles whose byline prints “Deo K Srivastava”
